April 08, 2025 16:05 ET | Source: Annexon Biosciences Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable…
Company to host conference call on April 7 at 8 a.m. ET April 06, 2025 12:00 ET | Source: Rhythm…
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Pivotal, the market leader in light electric vertical takeoff and landing…
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr…
– Launch-HTN met its primary endpoint with lorundrostat 50 mg dose achieving a 16.9 mmHg reduction in systolic blood pressure,…
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
March 07, 2025 16:01 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311, the world's…
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven…
